Head of Investor Relations
Kyverna Therapeutics, Inc. (KYTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Kyverna Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get KYTX alertsJessica is recorded as Head of Investor Relations at Kyverna Therapeutics, Inc. (KYTX). Jessica has spoken on 1 investor event across 1 company, most recently for Kyverna Therapeutics, Inc. on April 22, 2026. Kyverna Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Kyverna Therapeutics, Inc. includes Warner Biddle (CEO and Board Member), Christi Shaw (Chairman and Board Member), Greg Martini (CFO) and 7 others.
“We will be discussing the primary analysis from our KAISA-8 registrational trial of Miflecaptogene autolucel, or MIVCEL, formerly referred to as KYV-101 and stiff person syndrome, as well as longer-term follow-up data from our KAISA-6 phase 2 trial in generalized myasthenia gravis.”
Biotechnology · Healthcare
Head of Investor Relations
